Who owns iShares NASDAQ Biotechnology Index?

Key details on iShares NASDAQ Biotechnology Index (Ticker: IBB)

Who owns iShares NASDAQ Biotechnology Index?

Is IBB a good stock to own? Find out who bought iShares NASDAQ Biotechnology Index, who sold iShares NASDAQ Biotechnology Index (IBB) stock, and who holds a large position in iShares NASDAQ Biotechnology Index.

Fund Name Number of Shares Share Valuation As Of
GOLDMAN SACHS 2.36M $536.26M Dec. 31, 2013
Citi 2.16M $491.44M Dec. 31, 2013
Bank of America Corporation 1.49M $338.54M Dec. 31, 2013
Schroder Investment Management 1.37M $287.49M Sept. 30, 2013
MORGAN STANLEY 1.06M $240.86M Dec. 31, 2013
Archer Capital Management 980000 $81.15M March 31, 2012
SUSQUEHANNA INTERNATIONAL 774892 $176.00M Dec. 31, 2013
UBS AG 736704 $154.41M Sept. 30, 2013
Barclays 654589 $148.59M Dec. 31, 2013
Churchill Management 578282 $136.71M March 31, 2014
Allianz Asset Management AG 546441 $114.53M Sept. 30, 2013
Bank of Nova Scotia 456000 $103.54M Dec. 31, 2013
Deutsche Bank Aktiengesellschaft 422262 $95.88M Dec. 31, 2013
OrbiMed Advisors 350000 $43.16M March 31, 2012
HAP Trading 331377 $182257 Dec. 31, 2013
LPL Financial 319571 $45.57M Sept. 30, 2012
Arrowgrass Capital Partners 286600 $65.08M Dec. 31, 2013
Rathbones Brothers 276802 $8.89M March 31, 2014
Credit Suisse AG 275470 $47.90M June 30, 2013
Perceptive Advisors 269400 $46.84M June 30, 2013
DAVENPORT & CO 247785 $43.08M Sept. 30, 2013
JPMORGAN CHASE & CO 231695 $52.65M Dec. 31, 2013
Jefferies 211362 $27.47M June 30, 2012
Kingdon Capital Management 200000 $3.08M Sept. 30, 2013
Wells Fargo & Company 198479 $45.06M Dec. 31, 2013
FMR 195424 $44.37M Dec. 31, 2013
COMMERCE BANK N A/MO 192228 $40.29M Sept. 30, 2013
Neuberger Berman 183051 $22.57M Sept. 30, 2013
Smithwood Advisers 175000 $39.74M Dec. 31, 2013
Niemann Capital Management 171777 $21.18M March 31, 2012
Howard Capital Management 171500 $21.15M March 31, 2012
Jane Street Holding 167400 $38.01M Dec. 31, 2013

Who sold iShares NASDAQ Biotechnology Index?

Fund Name Date Sold Number of Shares Sold Share Valuation
Clark Capital Management Sept. 30, 2011 176652 $16.49M
Johnson Investment Counsel June 30, 2011 8.02M $543.35M
Royal Bank of Scotland June 30, 2011 710459 $75.78M